Balyasny Asset Management LLC Glaukos Corp Call Options Transaction History

Balyasny Asset Management LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	BUY	$34.86 - $63.77 $2.44 Million - $4.46 Million	70,000 New	70,000 $3.18 Million
Q4 2020 Feb 16, 2021	SELL	$48.9 - $75.26 $6.11 Million - $9.41 Million	-125,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$37.23 - $50.97 $3.31 Million - $4.54 Million	89,000 Added 247.22%	125,000 $6.19 Million
Q1 2019 May 15, 2019	BUY	$50.75 - $80.54 $1.83 Million - $2.9 Million	36,000 New	36,000 $2.82 Million

345

46.7M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.63B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.